Compare TSHA & BOBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSHA | BOBS |
|---|---|---|
| Founded | 2019 | 1991 |
| Country | United States | United States |
| Employees | N/A | 5950 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2020 | N/A |
| Metric | TSHA | BOBS |
|---|---|---|
| Price | $5.66 | $15.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 11 |
| Target Price | $11.63 | ★ $23.73 |
| AVG Volume (30 Days) | ★ 4.1M | 1.0M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,773,000.00 | N/A |
| Revenue This Year | N/A | $12.58 |
| Revenue Next Year | $1,152.42 | $7.43 |
| P/E Ratio | ★ N/A | $18.67 |
| Revenue Growth | ★ 17.28 | N/A |
| 52 Week Low | $2.53 | $9.74 |
| 52 Week High | $7.30 | $23.11 |
| Indicator | TSHA | BOBS |
|---|---|---|
| Relative Strength Index (RSI) | 43.52 | 53.30 |
| Support Level | $5.28 | $14.33 |
| Resistance Level | $6.01 | $16.70 |
| Average True Range (ATR) | 0.45 | 0.92 |
| MACD | -0.10 | -0.08 |
| Stochastic Oscillator | 24.09 | 41.41 |
Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.
Bobs Discount Furniture Inc operates as a furniture retailer offering a wide variety of merchandise assortments across several categories, including upholstery, case goods, bedding, and other. The company generates the majority of its revenue from the sale of its products through its retail stores.